HCM
HUTCHMED (China) LimitedNASDAQHealthcare$15.42+0.19%ClosedMarket Cap: $2.78B
As of 2026-04-06
Valuation
P/E (TTM)
5.96
PEG
0.00
P/B
2.12
P/S
5.87
EV/EBITDA
-1068.34
DCF Value
$-66.21
FCF Yield
-2.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.6%
Operating Margin
-2.6%
Net Margin
104.8%
ROE
41.4%
ROA
26.3%
ROIC
-0.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2025 | $550.0M | 38.7% | $-54.7M | $458.1M | $2.60 | — |
| Q2 2025 | $138.8M | 39.7% | $-1.8M | $227.5M | $1.30 | — |
| Q1 2025 | $138.8M | 39.7% | $-1.8M | $227.5M | $1.30 | — |
| Q4 2024 | $162.3M | -17.4% | $-8.1M | $6.0M | $0.04 | — |
| FY 2024 | $630.2M | 44.6% | $-43.7M | $37.7M | $0.22 | — |
| Q3 2024 | $162.3M | -17.4% | $-8.1M | $6.0M | $0.04 | — |
| Q2 2024 | $152.8M | 41.1% | $-13.8M | $12.9M | $0.07 | — |
| Q1 2024 | $152.8M | 41.1% | $-13.8M | $12.9M | $0.07 | — |
| Q4 2023 | $152.6M | 93.9% | $-46.6M | $-33.9M | $-0.20 | — |
| FY 2023 | $838.0M | 54.1% | $18.4M | $100.8M | $0.60 | — |
| Q3 2023 | $152.6M | -56.7% | $-46.6M | $-33.9M | $-0.20 | — |
| Q2 2023 | $266.4M | 60.9% | $55.8M | $84.3M | $0.49 | — |